JPRN-UMIN000025932已完成未知
The combination chemotherapy of carboplatin and TS-1 followed by the maintenance therapy of TS-1 in advanced non-small cell lung cancer. Phase 2 trial. - TS-1 plus CBDCA followed by TS-1 in advanced NSCLC
niversity of Fukui0 个研究点目标入组 25 人开始时间: 2017年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe drug allergy 2) Uncontrolable effusion 3) Within 2 weeks after radiotherapy for lesions except primary lesion. 4) Continuous watery diarrhea 5) Active double cancer 6) EGFR mutation positive or ALK fusion gene positive non-squamous cell carcinoma 7) Severe complications
研究者
相似试验
已完成
2 期
Carboplatin and TS-1 combination chemotherapy in cancer of unknown primary site : a phase II multicenter trialCancer of unknown primary siteJPRN-UMIN000023961ational Cancer Center Hospital35
已完成
2 期
Treatment outcome in head and neck cancer patients receiving carboplatin plus capecitabine based versus high dose cisplatin based chemoradiotherapy.CTRI/2020/11/029290Govt Kilpauk Medical College81
已完成
不适用
Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratomaCancerTesticular cancerISRCTN69711558Medical Research Council (MRC) (UK)450
招募中
2 期
Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal canceradvanced/metastatic colorectal cancerJPRN-UMIN000005900PO FMPC (Future Medicine Promoting Consortium)40
已完成
1 期
Combination chemotherapy of TS-1, oxaliplatin and irinotecan (TIROX) for unresectable gastric cancer; a phase I studygastric cancerJPRN-UMIN000030482Osaka Medical College Hospital18